Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Blitz who wrote (2834)	1/7/1999 11:04:00 AM
From: John R Resseger	Respond to of 3725

I think GE could get it into the Hospitals a lot quicker. Long term Imat on its own could take off. They would probably have to dilute the stock to get the operation humming. GE might be big hearted and pay up to $8.77 a share.

To: Blitz who wrote (2834)	1/7/1999 11:05:00 AM
From: Bruce Rozenblit	Read Replies (1) \| Respond to of 3725

If they could sell about 100 machines a year at a decent profit, I would expect the stock to trade for $15 to $20 a share. The question is, in which decade of the next century will that occur. A buyout will help us in the present but won't yield the maximum value for the company. The caveat here is that the company just may not have the resources or management to get to 100 machines a year. The financial history of the past 15 years gives every indication that this is so. It doesn't matter how good your crew is, how good your ship is, or how many hours per week you work. If the captain says to sail the ship into an iceberg, you're going down.